By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Patheon Inc. 

4815 Emperor Boulevard
Suite 300
Durham  North Carolina  27703-8580   U.S.A.
Phone: 919-226-3200 or 866 728 4366 Fax: n/a

Patheon Inc. (TSX: PTI) is a leading global provider of contract development and manufacturing services to the global pharmaceutical industry. The company provides the highest quality products and services to approximately 300 of the world’s leading pharmaceutical and biotechnology companies. Its services range from preclinical development through commercial manufacturing of a full array of dosage forms including parenteral, soft gel, solid and liquid forms.

The company’s comprehensive range of fully integrated Pharmaceutical Development Services includes pre-formulation, formulation, analytical development, clinical manufacturing, scale-up and commercialization. The company’s integrated development and manufacturing network of nine manufacturing facilities, nine development centers and one clinical trial material packaging facility across North America and Europe, enables customer products to be launched with confidence anywhere in the world.

Key Statistics

Ownership: Public

Web Site: Patheon
Employees: 4,000
Symbol: PTHN


Company News
Thermo Fisher Scientific (TMO) Completes Subsequent Offering Period Of Tender Offer Following Acquisition Of Patheon (PTHN) 9/13/2017 6:21:24 AM
Thermo Fisher Scientific (TMO) Completes Acquisition Of Patheon (PTHN) 8/29/2017 8:55:25 AM
Thermo Fisher Scientific (TMO) Announces Receipt Of All Required Regulatory Approvals For Proposed Acquisition Of Patheon (PTHN) 8/24/2017 7:01:19 AM
Patheon (PTHN) Announces Intent To Voluntarily Delist From The NYSE Subject To And Conditioned Upon The Initial Expiration Of The Tender Offer And Acquisition Of Shares By Thermo Fisher Scientific (TMO) 8/23/2017 7:56:20 AM
Thermo Fisher Scientific (TMO) Extends Cash Tender Offer For All Outstanding Shares Of Patheon (PTHN) To Coordinate Offer Timing With Two Remaining Regulatory Approvals 8/8/2017 7:45:55 AM
Patheon (PTHN) To Invest $45 Million, Expanding Capabilities To Support Continued Growth 6/29/2017 10:56:02 AM
After Bagging Patheon (PTHN) for $7.2 Billion, This Could be Thermo Fisher Scientific (TMO)'s New Target 6/14/2017 6:22:27 AM
Patheon (PTHN) Reports Fiscal 2017 Second Quarter 6/8/2017 8:25:06 AM
Fortress Biotech (FBIO) Subsidiary Caelum Biosciences Enters Biopharmaceutical Manufacturing Agreement With Patheon (PTHN) 6/1/2017 11:16:22 AM
Did Patheon (PTHN) Get Enough In Its Buyout? 5/16/2017 6:23:12 AM